Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

Completed · Phase 3

Conditions studied: Vulvar Cancer

In brief

RATIONALE: Lymphatic mapping may improve the ability to detect cancer of the vulva. PURPOSE: This phase III trial is studying how well lymphatic mapping works in treating patients with stage I or stage II cancer of the vulva.

Key facts

Study ID
NCT00003325
Run by
Gynecologic Oncology Group
People needed
515
Starts
1999-12-01
Last updated by the study team
2015-05-29

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.